<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.clinicalendocrinologynews.com/?rss=yes"><title>Clinical Endocrinology News</title><description>Clinical Endocrinology News RSS feed: Current Issue. </description><link>http://www.clinicalendocrinologynews.com/?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2012 Elsevier Inc. All rights reserved. </dc:rights><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:issn>1558-0164</prism:issn><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:publicationDate>January 2012</prism:publicationDate><prism:copyright> © 2012 Elsevier Inc. All rights reserved. </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700019/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700020/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700032/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700044/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700056/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700068/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS155801641270007X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700081/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700093/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS155801641270010X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700111/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700123/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700135/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700147/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700159/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700160/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700172/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700184/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700196/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700202/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700214/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700226/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700238/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS155801641270024X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700251/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700263/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700275/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700287/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700299/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700305/abstract?rss=yes"/><rdf:li rdf:resource="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700317/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700019/abstract?rss=yes"><title>Blood Glucose Testing for All Inpatients, Group Says</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700019/abstract?rss=yes</link><description>All patients admitted to the hospital in noncritical care settings should have their blood glucose tested, according to a new clinical practice guideline from the Endocrine Society.</description><dc:title>Blood Glucose Testing for All Inpatients, Group Says</dc:title><dc:creator>MIRIAM E. TUCKER</dc:creator><dc:identifier>10.1016/S1558-0164(12)70001-9</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>News</prism:section><prism:startingPage>1</prism:startingPage><prism:endingPage>2</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700020/abstract?rss=yes"><title>DXA Payments Slated to Plummet March 1</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700020/abstract?rss=yes</link><description>Medicare payments for the use of dual-energy x-ray absorptiometry are set to drop on March 1 unless Congress acts to extend the current payment rates for the screening procedure.</description><dc:title>DXA Payments Slated to Plummet March 1</dc:title><dc:creator>Mary Ellen Schneider</dc:creator><dc:identifier>10.1016/S1558-0164(12)70002-0</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>News</prism:section><prism:startingPage>1</prism:startingPage><prism:endingPage>1</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700032/abstract?rss=yes"><title>Progesterone Quells Some Catamenial Seizures</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700032/abstract?rss=yes</link><description>
					
				   Major Finding: Cyclical natural progesterone therapy decreased seizure frequency by up to 71%, compared with placebo, in women with a high number of perimenstrual seizures.</description><dc:title>Progesterone Quells Some Catamenial Seizures</dc:title><dc:creator>MICHELE G. SULLIVAN</dc:creator><dc:identifier>10.1016/S1558-0164(12)70003-2</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>News</prism:section><prism:startingPage>3</prism:startingPage><prism:endingPage>3</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700044/abstract?rss=yes"><title>NAFLD Common in Teenage Girls With PCOS</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700044/abstract?rss=yes</link><description>
					
				   Major Finding: A total of 43% of teenage girls with polycystic ovary syndrome have concomitant nonalcoholic fatty liver disease.</description><dc:title>NAFLD Common in Teenage Girls With PCOS</dc:title><dc:creator>M. ALEXANDER OTTO</dc:creator><dc:identifier>10.1016/S1558-0164(12)70004-4</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>News</prism:section><prism:startingPage>3</prism:startingPage><prism:endingPage>3</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700056/abstract?rss=yes"><title>Recent Diabetes Tied to Breast Cancer Risk</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700056/abstract?rss=yes</link><description>SAN ANTONIO – Diagnosis of diabetes within the prior 4 years was independently associated with breast cancer in a Swedish case-control study.   Dr. Håkan Olsson reported on all 2,724 women diagnosed with breast cancer in southern Sweden during 2005-2007 and 20,542 matched controls. He and his coworkers were interested in how the malignancy is related to diabetes, obesity, and serum lipid levels.</description><dc:title>Recent Diabetes Tied to Breast Cancer Risk</dc:title><dc:creator>BRUCE JANCIN</dc:creator><dc:identifier>10.1016/S1558-0164(12)70005-6</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>News</prism:section><prism:startingPage>8</prism:startingPage><prism:endingPage>8</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700068/abstract?rss=yes"><title>Purified Fish Oil Cut Triglycerides by 21%</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700068/abstract?rss=yes</link><description>
					
				   Major Finding: A 12-week treatment regimen of 4 g/day of a purified formulation of EPA produced a 21.5% placebo-corrected cut in triglyceride levels in patients on statin treatment who began with a triglyceride level greater than 200 mg/dL and less than 500 mg/dL.</description><dc:title>Purified Fish Oil Cut Triglycerides by 21%</dc:title><dc:creator>MITCHEL L. ZOLER</dc:creator><dc:identifier>10.1016/S1558-0164(12)70006-8</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>News</prism:section><prism:startingPage>9</prism:startingPage><prism:endingPage>9</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS155801641270007X/abstract?rss=yes"><title>FDA Issues Artificial Pancreas Guidance</title><link>http://www.clinicalendocrinologynews.com/article/PIIS155801641270007X/abstract?rss=yes</link><description>The Food and Drug Administration has issued draft guidance to assist investigators and manufacturers in the development of artificial pancreas device systems to treat type 1 diabetes.</description><dc:title>FDA Issues Artificial Pancreas Guidance</dc:title><dc:creator>MIRIAM E. TUCKER</dc:creator><dc:identifier>10.1016/S1558-0164(12)70007-X</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>News</prism:section><prism:startingPage>10</prism:startingPage><prism:endingPage>10</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700081/abstract?rss=yes"><title>Islet Cell Autografts Relieve Chronic Pancreatitis Pain</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700081/abstract?rss=yes</link><description>
					
				   Major Finding: Ninety-seven percent of autotransplant patients in the most recent cohort (2006-2011) were alive at 1 year. At 5 years, 86%-88% of the earlier transplants patients were still alive. Twenty-year survival is 66%. Pancreatitis pain resolved in 80%-90% of patients overall.</description><dc:title>Islet Cell Autografts Relieve Chronic Pancreatitis Pain</dc:title><dc:creator>ALICIA AULT</dc:creator><dc:identifier>10.1016/S1558-0164(12)70008-1</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>News</prism:section><prism:startingPage>10</prism:startingPage><prism:endingPage>10</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700093/abstract?rss=yes"><title>Cutting Calories Yielded Lasting Cardiac Benefit</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700093/abstract?rss=yes</link><description>CHICAGO – Four months of a restricted-calorie diet produced lasting reductions in pericardial fat and improvements in left ventricular diastolic function in a study of obese adults with type 2 diabetes.</description><dc:title>Cutting Calories Yielded Lasting Cardiac Benefit</dc:title><dc:creator>SUSAN BIRK</dc:creator><dc:identifier>10.1016/S1558-0164(12)70009-3</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Diabetes</prism:section><prism:startingPage>11</prism:startingPage><prism:endingPage>11</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS155801641270010X/abstract?rss=yes"><title>Intensive Glycemic Control Protects Kidneys</title><link>http://www.clinicalendocrinologynews.com/article/PIIS155801641270010X/abstract?rss=yes</link><description>PHILADELPHIA – Early, intensive treatment for type 1 diabetes with conventional therapy halves the long-term risk of developing an impaired glomerular filtration rate, the common pathway leading to end-stage kidney disease, Dr. Ian H. de Boer said at the meeting.</description><dc:title>Intensive Glycemic Control Protects Kidneys</dc:title><dc:creator>DIANA MAHONEY</dc:creator><dc:identifier>10.1016/S1558-0164(12)70010-X</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Diabetes</prism:section><prism:startingPage>12</prism:startingPage><prism:endingPage>12</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700111/abstract?rss=yes"><title>Diabetes Quadruples Risk of Liver Disease</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700111/abstract?rss=yes</link><description>SAN FRANCISCO – Health care providers should be aware that adult patients with diabetes have a sharply increased risk for chronic liver disease and should be counseled accordingly, advised investigators with the Centers for Disease Control and Prevention.</description><dc:title>Diabetes Quadruples Risk of Liver Disease</dc:title><dc:creator>SUSAN LONDON</dc:creator><dc:identifier>10.1016/S1558-0164(12)70011-1</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Diabetes</prism:section><prism:startingPage>13</prism:startingPage><prism:endingPage>13</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700123/abstract?rss=yes"><title>Metabolic Syndrome Strikes Hard in Psoriatic Patients</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700123/abstract?rss=yes</link><description>CHICAGO – Metabolic syndrome is significantly more common in patients with psoriatic arthritis than in those with rheumatoid arthritis, data on nearly 2,000 adults show.   Previous studies have suggested that metabolic syndrome is associated with “a state of chronic, low-grade inflammation,” said Dr. Asena Bahce-Altuntas of Albert Einstein College of Medicine in New York. “Since psoriatic arthritis [PsA] is characterized by inflammation of both skin and joints, we may be underestimating this cardiovascular risk in PsA,” she said at the meeting.</description><dc:title>Metabolic Syndrome Strikes Hard in Psoriatic Patients</dc:title><dc:creator>HEIDI SPLETE</dc:creator><dc:identifier>10.1016/S1558-0164(12)70012-3</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Diabetes</prism:section><prism:startingPage>13</prism:startingPage><prism:endingPage>13</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700135/abstract?rss=yes"><title>Comorbid Psoriasis Adds Hefty Economic Burden</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700135/abstract?rss=yes</link><description>LISBON – Psoriasis and diabetes are expensive diseases, and patients with both conditions experience a synergistic increase in health care utilization and costs that is significantly greater than the incremental economic burden imposed by each disease individually.</description><dc:title>Comorbid Psoriasis Adds Hefty Economic Burden</dc:title><dc:creator>BRUCE JANCIN</dc:creator><dc:identifier>10.1016/S1558-0164(12)70013-5</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Diabetes</prism:section><prism:startingPage>13</prism:startingPage><prism:endingPage>13</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700147/abstract?rss=yes"><title>Mediterranean Diet May Be Effective in NAFLD</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700147/abstract?rss=yes</link><description>SAN FRANCISCO – The Mediterranean diet may be superior to the low-fat diet for decreasing hepatic fat and increasing insulin sensitivity in patients with nonalcoholic fatty liver disease, based on a small randomized crossover study conducted in Australia.</description><dc:title>Mediterranean Diet May Be Effective in NAFLD</dc:title><dc:creator>SUSAN LONDON</dc:creator><dc:identifier>10.1016/S1558-0164(12)70014-7</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Diabetes</prism:section><prism:startingPage>16</prism:startingPage><prism:endingPage>17</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700159/abstract?rss=yes"><title>CPAP Aids Metabolic Syndrome in Apnea Patients</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700159/abstract?rss=yes</link><description>
					
				   Major Finding: The metabolic syndrome resolved in 11 of 86 patients after CPAP therapy, compared with 1 of those same patients after sham therapy. The treatment also significantly improved systolic and diastolic BP; total, LDL, and non-HDL cholesterol; triglycerides; glycated hemoglobin; weight; and visceral and subcutaneous fat.</description><dc:title>CPAP Aids Metabolic Syndrome in Apnea Patients</dc:title><dc:creator>MARY ANN MOON</dc:creator><dc:identifier>10.1016/S1558-0164(12)70015-9</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Obesity</prism:section><prism:startingPage>18</prism:startingPage><prism:endingPage>18</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700160/abstract?rss=yes"><title>High Systolic BP and LDL Predict Different Events</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700160/abstract?rss=yes</link><description>ORLANDO – Although higher systolic blood pressure and LDL cholesterol are traditional risk factors for cardiovascular disease, each may have a different effect on the cerebrovascular and coronary systems.</description><dc:title>High Systolic BP and LDL Predict Different Events</dc:title><dc:creator>NASEEM S. MILLER</dc:creator><dc:identifier>10.1016/S1558-0164(12)70016-0</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Obesity</prism:section><prism:startingPage>18</prism:startingPage><prism:endingPage>18</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700172/abstract?rss=yes"><title>Weigh Surgical Options for Metabolic Syndrome</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700172/abstract?rss=yes</link><description>HOT SPRINGS, VA. – An analysis of a large database of bariatric surgery patients has found that those with metabolic syndrome had dramatic improvements in comorbidities but a slightly higher rate of adverse events after 90 days.</description><dc:title>Weigh Surgical Options for Metabolic Syndrome</dc:title><dc:creator>ALICIA AULT</dc:creator><dc:identifier>10.1016/S1558-0164(12)70017-2</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Obesity</prism:section><prism:startingPage>19</prism:startingPage><prism:endingPage>19</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700184/abstract?rss=yes"><title>Iron Deficiency ‘Unintended Consequence’ of Gastric Bypass</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700184/abstract?rss=yes</link><description>SAN DIEGO – About one-quarter of patients referred to a group hematology practice had iron deficiency associated with gastric bypass surgery, a study has shown.   In addition, 57% demonstrated symptoms of pica syndrome – a craving for and compulsive eating of nonfood substances such as ice and starch.</description><dc:title>Iron Deficiency ‘Unintended Consequence’ of Gastric Bypass</dc:title><dc:creator>DOUG BRUNK</dc:creator><dc:identifier>10.1016/S1558-0164(12)70018-4</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Obesity</prism:section><prism:startingPage>19</prism:startingPage><prism:endingPage>19</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700196/abstract?rss=yes"><title>Early Factors Can Predict NAFLD in Adolescence</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700196/abstract?rss=yes</link><description>SAN FRANCISCO – Factors that can be measured in the first few years of life can predict whether a child will develop nonalcoholic fatty liver disease (NAFLD) by adolescence, suggests a study presented at the meeting.</description><dc:title>Early Factors Can Predict NAFLD in Adolescence</dc:title><dc:creator>SUSAN LONDON</dc:creator><dc:identifier>10.1016/S1558-0164(12)70019-6</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Obesity</prism:section><prism:startingPage>20</prism:startingPage><prism:endingPage>20</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700202/abstract?rss=yes"><title>Low-Protein Diet May Cause Less Weight Gain, More Fat</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700202/abstract?rss=yes</link><description>Overeating on a diet low in protein caused less weight gain than overeating on a normal- or high-protein diet – but most of the body mass gained was fat, rather than the leaner muscle mass created by high-protein overeating, according to a recent report.</description><dc:title>Low-Protein Diet May Cause Less Weight Gain, More Fat</dc:title><dc:creator>MARY ANN MOON</dc:creator><dc:identifier>10.1016/S1558-0164(12)70020-2</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Obesity</prism:section><prism:startingPage>20</prism:startingPage><prism:endingPage>20</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700214/abstract?rss=yes"><title>‘50% Rule’ May Not Apply in Subset of Patients</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700214/abstract?rss=yes</link><description>
					
				   Major Finding: Patients with less than a 50% drop in intraoperative parathyroid hormone level (IOPTH) did not differ from those with a drop of greater than or equal to 50% in terms of age, gender, symptoms, presence of hypercalcemia, preoperative localization, or median size or weight of the gland. But patients with less than a 50% drop in IOPTH were more likely to have single adenomas.</description><dc:title>‘50% Rule’ May Not Apply in Subset of Patients</dc:title><dc:creator>CAROLINE HELWICK</dc:creator><dc:identifier>10.1016/S1558-0164(12)70021-4</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Pituitary, Thyroid &amp; Adrenal</prism:section><prism:startingPage>22</prism:startingPage><prism:endingPage>22</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700226/abstract?rss=yes"><title>Early Oophorectomy Linked to Osteoporosis and Arthritis</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700226/abstract?rss=yes</link><description>SAN ANTONIO – Bilateral oophorectomy in women younger than age 45 is associated with a subsequent doubled prevalence of osteoporosis and a similarly elevated rate of arthritis, compared with women with intact ovaries.</description><dc:title>Early Oophorectomy Linked to Osteoporosis and Arthritis</dc:title><dc:creator>BRUCE JANCIN</dc:creator><dc:identifier>10.1016/S1558-0164(12)70022-6</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Osteoporosis</prism:section><prism:startingPage>23</prism:startingPage><prism:endingPage>23</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700238/abstract?rss=yes"><title>New Anticonvulsants Did Not Impair Bone Density in VA Study</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700238/abstract?rss=yes</link><description>SAN DIEGO – Newer anticonvulsants do not appear to be associated with the reduced bone mineral density seen with traditional anticonvulsants, based on results from a retrospective Veterans Affairs study.</description><dc:title>New Anticonvulsants Did Not Impair Bone Density in VA Study</dc:title><dc:creator>BRUCE JANCIN</dc:creator><dc:identifier>10.1016/S1558-0164(12)70023-8</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Osteoporosis</prism:section><prism:startingPage>23</prism:startingPage><prism:endingPage>23</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS155801641270024X/abstract?rss=yes"><title>Analysis Challenges Link Between Vitamin D Deficiency and Cancer</title><link>http://www.clinicalendocrinologynews.com/article/PIIS155801641270024X/abstract?rss=yes</link><description>SAN ANTONIO – A new meta-analysis of 16 studies challenges the notion that breast cancer risk is inversely related to serum vitamin D level.   In 10 studies, vitamin D was measured before diagnosis of breast cancer; in the other 6 studies, blood samples were gathered for vitamin D measurement only after the diagnosis.</description><dc:title>Analysis Challenges Link Between Vitamin D Deficiency and Cancer</dc:title><dc:creator>Bruce Jancin</dc:creator><dc:identifier>10.1016/S1558-0164(12)70024-X</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Osteoporosis</prism:section><prism:startingPage>23</prism:startingPage><prism:endingPage>23</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700251/abstract?rss=yes"><title>Low Vitamin D Levels Tied to Psychotic Symptoms in Teens</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700251/abstract?rss=yes</link><description>TORONTO – Low vitamin D levels were linked with more psychotic features in mentally ill adolescents, in a small study.   Studies have linked vitamin D deficiency with seasonal affective disorder, schizophrenia, and depression, Dr. Barbara L. Gracious of Ohio State University, Columbus, said at the meeting. She and her colleagues studied 104 consecutive teens seen for acute or partial hospital stays for psychiatric symptoms over an 18-month period. Patients' average age was 15, 27% were male, and 73% were white. Overall, 72% had low vitamin D levels (25-OHD levels less than 30 ng/mL), and 34% were vitamin D deficient (25-OHD levels less than 20 ng/mL). By comparison, 9% of a cohort of teens from the NHANES (National Health and Nutrition Survey) were vitamin D deficient, the researchers noted.</description><dc:title>Low Vitamin D Levels Tied to Psychotic Symptoms in Teens</dc:title><dc:creator>Heidi Splete</dc:creator><dc:identifier>10.1016/S1558-0164(12)70025-1</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Osteoporosis</prism:section><prism:startingPage>23</prism:startingPage><prism:endingPage>23</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700263/abstract?rss=yes"><title>FDA's Steps to Avert Shortages Under Scrutiny: FDA to require manufacturers of some drugs to give early warning of impending supply problems.</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700263/abstract?rss=yes</link><description>WASHINGTON – As a Senate committee held a hearing Dec. 15 on the continuing drug shortage problem, the Food and Drug Administration announced that it would require some manufacturers to give the agency early warning of an imminent shortage.</description><dc:title>FDA's Steps to Avert Shortages Under Scrutiny: FDA to require manufacturers of some drugs to give early warning of impending supply problems.</dc:title><dc:creator>ALICIA AULT</dc:creator><dc:identifier>10.1016/S1558-0164(12)70026-3</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Practice Trends</prism:section><prism:startingPage>24</prism:startingPage><prism:endingPage>24</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700275/abstract?rss=yes"><title>Proposed Health Exchange Benefits ‘Skimpy,’ Providers Say</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700275/abstract?rss=yes</link><description>Physicians who support a single-payer health system are urging the federal government to reject the Institute of Medicine's recommendations for designing the benefits package to be offered in the state-based health insurance exchanges.</description><dc:title>Proposed Health Exchange Benefits ‘Skimpy,’ Providers Say</dc:title><dc:creator>MARY ELLEN SCHNEIDER</dc:creator><dc:identifier>10.1016/S1558-0164(12)70027-5</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Practice Trends</prism:section><prism:startingPage>24</prism:startingPage><prism:endingPage>24</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700287/abstract?rss=yes"><title>e-Prescribing Survey Pinpoints Bottlenecks</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700287/abstract?rss=yes</link><description>Electronic prescribing is getting better, but challenges remain related to e-renewals, mail-order pharmacy connectivity, and pharmacy processing of e-prescriptions, based on survey results from 114 individuals involved in e-prescribing in 97 health care organizations.</description><dc:title>e-Prescribing Survey Pinpoints Bottlenecks</dc:title><dc:creator>FRANCES CORREA</dc:creator><dc:identifier>10.1016/S1558-0164(12)70028-7</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Practice Trends</prism:section><prism:startingPage>25</prism:startingPage><prism:endingPage>25</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700299/abstract?rss=yes"><title>Texas Tort Reform: More Complaints, Lower Costs</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700299/abstract?rss=yes</link><description>HOT SPRINGS, VA. – Since tort reform in Texas, the number of lawsuits and associated costs have decreased, but patient complaints to the state medical board and board investigations of physicians have risen, according to an analysis presented at the meeting.</description><dc:title>Texas Tort Reform: More Complaints, Lower Costs</dc:title><dc:creator>ALICIA AULT</dc:creator><dc:identifier>10.1016/S1558-0164(12)70029-9</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Practice Trends</prism:section><prism:startingPage>25</prism:startingPage><prism:endingPage>25</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700305/abstract?rss=yes"><title>The Physician Payments Sunshine Act</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700305/abstract?rss=yes</link><description>The Physician Payments Sunshine Act, a provision of the Affordable Care Act, aims to bring transparency to the practice of pharmaceutical and device companies providing meals, gifts, and payments to physicians. It requires that these companies, as well as biologic manufacturers and medical suppliers, report any “payment or other transfer of value” of $10 or greater to physicians and teaching hospitals. The manufacturer must report alltpayments to a single physician if they reach $100 in aggregate value for a year. The Centers for Medicare and Medicaid Services released a proposed ruleonn December 2011 outlining how the disclosures would work. Drug and device manufacturers can hold off collecting information until the CMS issues a final rule later this year. Sine agency predicted that the first reports required under the Physician Payments Sunshine Act will be publicly available by Sept. 30, 2013.</description><dc:title>The Physician Payments Sunshine Act</dc:title><dc:creator></dc:creator><dc:identifier>10.1016/S1558-0164(12)70030-5</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Implementing Health Reform</prism:section><prism:startingPage>26</prism:startingPage><prism:endingPage>26</prism:endingPage></item><item rdf:about="http://www.clinicalendocrinologynews.com/article/PIIS1558016412700317/abstract?rss=yes"><title>Policy &amp; Practice: Want more health reform news? Subscribe to our podcast – search ‘Policy &amp; Practice’ in the iTunes store</title><link>http://www.clinicalendocrinologynews.com/article/PIIS1558016412700317/abstract?rss=yes</link><description>Adolescents and young adults with diabetes are 6% more likely to drop out of school than are those without the disease, according to Health Affairs report. The disparity is similar to the difference in dropout rates seen between young people who have attention deficit–hyperactivity disorder and those without ADHD, the study showedaInyoung adults with diabetes can expect to earn $160,000 less in wages over their working lives, compared with adults without the condition, said the researchers at Yale University, New Haven, Conn. By age 30, a person with diabetes can expect to have a 10-percentage-point reduction in the likelihood of being employed – in part because of reduced education – and to earn $6,000 less each year, compared with peers who do not have diabetes, the researchers said.</description><dc:title>Policy &amp; Practice: Want more health reform news? Subscribe to our podcast – search ‘Policy &amp; Practice’ in the iTunes store</dc:title><dc:creator>Naseem S. Miller</dc:creator><dc:identifier>10.1016/S1558-0164(12)70031-7</dc:identifier><dc:source>Clinical Endocrinology News 7, 1 (2012)</dc:source><dc:date>2012-01-01</dc:date><prism:publicationName>Clinical Endocrinology News</prism:publicationName><prism:publicationDate>2012-01-01</prism:publicationDate><prism:volume>7</prism:volume><prism:number>1</prism:number><prism:issueIdentifier>S1558-0164(12)X7001-9</prism:issueIdentifier><prism:section>Section</prism:section><prism:startingPage>26</prism:startingPage><prism:endingPage>26</prism:endingPage></item></rdf:RDF>
